Ticagrelor versus clopidogrel in individuals with acute coronary syndromes. inflammatory mediators, platelet activation and subsequent thrombosis. Although ASA is definitely well established as first-line therapy in acute coronary syndromes, 2 fresh evidence helps the part of newer antiplatelet providers. In this article, we review recent advances and practical applications of the new antiplatelet providers, specifically […]